𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Posttransfusion purpura associated with alloantibody specific for the platelet antigen, Pena

✍ Scribed by Dr. Toby L. Simon; Janice Collins; Thomas J. Kunicki; Kenichi Furihata; Kenneth J. Smith; Richard H. Aster

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
321 KB
Volume
29
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Post-transfusion purpura associated with
Post-transfusion purpura associated with alloimmunization against the platelet-specific antigen, baka
✍ Rudolph M. Keimowitz; Janice Collins; Kent Davis; Richard H. Aster 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 649 KB

Post-transfusion purpura (PTP) with severe thrombocytopenia occurred eight days after transfusion in a 28-year-old woman and responded to treatment with prednisone and plasma exchange. In contrast to nearly all previously studied cases of PTP, the patient's platelets were PlA1-positive and anti-Pl\*

mRNA expression of leukemia-associated a
mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies
✍ Jochen Greiner; Mark Ringhoffer; Masanori Taniguchi; Li Li; Anita Schmitt; Hiros 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 155 KB 👁 1 views

## Abstract Specific immunotherapies for patients with acute myeloid leukemia (AML) using leukemia‐associated antigens (LAA) as target structures might be a therapeutic option to enhance the graft‐__vs__.‐leukemia effect observed after allogeneic stem cell transplantation or to prolong a complete r

Target cell-restricted and -enhanced apo
Target cell-restricted and -enhanced apoptosis induction by a scFv:sTRAIL fusion protein with specificity for the pancarcinoma-associated antigen EGP2
✍ Edwin Bremer; Jos Kuijlen; Douwe Samplonius; Henning Walczak; Lou de Leij; Wijna 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 240 KB

## Abstract The apparent tumor selective apoptosis‐inducing activity of recombinant soluble TNF‐related apoptosis‐inducing ligand (TRAIL) has aroused much interest for use in clinical application. However, to exploit fully its therapeutic potential, the characteristics of both the TRAIL receptor sy

Pretreatment prostate-specific antigen v
Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy
✍ David Palma; Scott Tyldesley; Tom Pickles; for the Prostate Cohort Outcomes Init 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

## Abstract ## BACKGROUND In men with prostate cancer, pretreatment prostate‐specific antigen (PSA) velocity (PSAV) has been demonstrated as a predictor of biochemical and survival outcomes in patients undergoing radical prostatectomy (RP). The utility of pretreatment PSAV in predicting outcomes a